Biotechnology

Inside Hims’ Earnings Call: CEO Tackles GLP-1 Compounding Concerns Head-On
In recent times, telehealth company Hims & Hers has sparked discussions about compounded GLP-1 weight loss medications. During a recent ... Read more

Grail’s Cancer Detection Test Faces Major Setback: What It Means for Future Diagnostics
Grail, a company known for its innovative cancer detection technology, recently faced a setback. Its blood test, Galleri, did not ... Read more

FDA Changes Its Stance: A New Review of Moderna’s Flu Vaccine is on the Horizon!
The FDA recently announced it will review Moderna’s application for a new flu vaccine, specifically for adults aged 50 and ... Read more

Insights from Moderna’s President: What the FDA’s Decision on the Flu Vaccine Means for You
In August, the FDA assured Moderna it would review its application for a new flu vaccine. This promise was based ... Read more

FDA Chief Prasad Reverses Staff Decision: Moderna’s Flu Vaccine Application Denied
Vinay Prasad, a leading figure at the FDA, made a significant decision recently by rejecting Moderna’s request for a new ... Read more

Revolutionary Point-of-Use Colorimetric Detection of E. Coli in Food Using DNAzyme-Enhanced Hydrogels
Understanding Foodborne Pathogens Foodborne pathogens are a major concern for public health. Every year, millions get sick from contaminated food. ... Read more

Eli Lilly Surpasses Quarterly Expectations with Soaring Zepbound and Mounjaro Sales: A Promising Outlook Ahead!
Eli Lilly is making big waves in the pharmaceutical world. They recently shared impressive fourth-quarter earnings that exceeded what analysts ... Read more

Eli Lilly Unveils $3.5 Billion Pennsylvania Plant for Next-Gen Obesity Injections: What This Means for You
Eli Lilly is making a big move to tackle obesity with a new manufacturing plant in Pennsylvania’s Lehigh Valley. The ... Read more


